11:20 AM EST, 11/04/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts started the week tracking higher late Monday morning, rising 0.49% to 1,366.51 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and internet advertising firm Criteo ( CRTO ) , which rose 4.4% and 4.8% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) and tech conglomerate Philips (PHG), which increased 3% and 2.7% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Novo Nordisk ( NVO ) , which fell 5.1% and 1.6% respectively. They were followed by 3D printer company Materialise (MTLS) and biotech firm BioNTech (BNTX), which were down 1.6% and 1.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Bicycle Therapeutics ( BCYC ) , which were up 5.9% and 4.2% respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and NuCana ( NCNA ) , which rose 2.8% and 2.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Biodexa Pharmaceuticals ( BDRX ) , which lost 5.3% and 1.9% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Trinity Biotech ( TRIB ) 2.4% and 2.3% respectively.